Warning: Undefined array key 0 in /var/www/hoodb/function.php on line 154

Warning: Trying to access array offset on value of type null in /var/www/hoodb/function.php on line 154

China approves Alzheimer's treatment Leqembi by Eisai and Biogen

2024-05-04 02:01:23 | エーザイ

You are leaving and open the following URL" of about "エーザイ" news

news.google.com/rss/articles/CBMigwFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9jaGluYS1hcHByb3Zlcy1hbHpoZWltZXJzLXRyZWF0bWVudC1sZXFlbWJpLWJ5LWVpc2FpLWJpb2dlbi0yMDI0LTAxLTA5L9IBAA?oc=5

Continue Opne >

エーザイ: China approves Alzheimer's treatment Leqembi by Eisai and Biogen

More エーザイ news:

2024-04-01 07:00 Eisai, Biogen's subQ Leqembi delayed amid FDA's data request - FiercePharma
2024-04-18 19:08 With support from Eisai, Mission Based Media launches Alzheimer's podcast series - MM+M Online
2024-03-22 07:00 EU regulator delays decision on Eisai-Biogen Alzheimer's drug - Reuters.com
2024-04-11 07:00 Medicare estimates $3.5 billion cost on Alzheimer's drug Leqembi - STAT
2024-04-01 07:00 Biogen and Eisai Fall Behind on Leqembi’s Subcutaneous BLA for Alzheimer’s - BioSpace
2024-04-01 07:00 Eisai and Biogen move to bring IV maintenance dosing for Leqembi to the US - Pharmaceutical Technology
2024-03-06 08:00 Eisai to drop up to $15M on C2N Diagnostics to boost the reach of Alzheimer's disease blood tests - Fierce Biotech
2024-04-04 07:00 Eisai seeks FDA approval of Leqembi IV maintenance dosing - Alzheimer's News Today
2024-03-26 07:00 CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug - Yahoo Finance

2024-01-10 08:00 Eisai harnesses wearables data for AI-led Alzheimer's prediction - Mobihealth News
2023-10-25 07:00 Eisai Presents New LEQEMBI® (lecanemab-irmb) Investigational Subcutaneous Formulation Interim Study Results and ... - Biogen
2024-04-12 15:58 Eisai supports creation of Alzheimer's podcast miniseries - FiercePharma
2024-03-07 08:00 Japan's Eisai says US introduction of Alzheimer's drug Leqembi slower than expected - Reuters.com
2024-04-02 07:00 Eisai signs agreement to divest rights for two therapies to Kaken - Pharmaceutical Technology
2024-02-07 08:00 Eisai to Likely Miss Patient Goal for Leqembi by End of March 2024 - BioSpace
2024-04-05 07:00 Eisai, Carvykti, Ozempic biosimilar—Fierce Pharma Asia - FiercePharma
2024-02-05 08:00 Exclusive: Eisai expects 1500 Alzheimer's patients in China launch, sees 'huge' growth - Reuters.com
2024-03-08 08:00 Fierce Pharma Asia—Eisai's Leqembi outlook; Sumitomo's downsizing; Kyowa Kirin's expansion - FiercePharma
2024-01-09 08:00 China approves Alzheimer's treatment Leqembi by Eisai and Biogen - Reuters.com

2024-02-27 08:00 Neurologists paint bleak Leqembi launch picture as Alzheimer's drug trips up on a host of challenges - FiercePharma
2024-04-14 20:41 It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start? - The Columbian
2024-03-07 08:00 Despite Leqembi's launch pains, Eisai projects Alzheimer's med will reach $8.8B in the long run - FiercePharma
2023-12-13 08:00 Eisai to launch Alzheimer's drug Leqembi in Japan on Dec 20 - Reuters.com
2023-10-26 07:00 Injected version of Eisai/Biogen Alzheimer's drug works as well as IV Leqembi - Reuters.com
2023-10-24 07:00 Eisai & Biogen Leqembi: The 200 Best Inventions of 2023 - TIME
2023-08-25 07:00 Merck, Eisai discontinue late-stage study for combo cancer therapy - Reuters.com
2023-12-08 08:00 Merck-Eisai's endometrial cancer therapy combo fails first-line treatment trial - Reuters.com
2024-03-08 08:00 Eisai Details Continued Leqembi Development Plans, Including New Dosing, Delivery Methods - Precision Medicine Online
2024-03-07 08:00 Japan's Eisai to invest in U.S. Alzheimer's blood testing firm C2N - Nikkei Asia

2024-02-07 08:00 Eisai's Leqembi rollout moves slower than expected - FiercePharma
2023-11-08 08:00 Eisai Sees ‘Dramatic’ Increase in Leqembi Uptake Following Full FDA Approval - BioSpace
2024-02-01 08:00 After Eisai retirement, Ivan Cheung is back to lead Massachusetts biotech - Fierce Biotech
2023-10-25 07:00 Under-the-skin injection of Eisai's Leqembi is as effective as IV infusion, new Alzheimer's data show - STAT
2024-03-19 07:00 Why Eisai is one of the most innovative medicines and therapeutics companies of 2024 - Fast Company
2024-03-07 08:00 SA e-health startup RecoMed secures funding from Japanese pharma Eisai - - Disrupt Africa
2023-10-25 07:00 Biogen and Eisai release new Alzheimer’s drug data that may support wider uptake - MarketWatch
2023-09-25 07:00 Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen - Reuters.com
2023-12-08 08:00 MSD's Keytruda and Eisai's Lenvima fail in Phase III uterine cancer trial - Pharmaceutical Technology
2024-02-02 08:00 Ex-Eisai leader Ivan Cheung to be new NextPoint CEO—Chutes & Ladders - Fierce Biotech

2024-02-16 08:00 No Playbook For Leqembi Eisai's Long Game In Alzheimer's Disease - Life Science Leader Magazine
2023-11-06 08:00 Eisai Shares Drop on Outlook Even With Alzheimer's Drug Sales - Bloomberg
2023-10-25 07:00 Eisai Alzheimer Drug Shows Promise in Injectable-At-Home Version - Bloomberg
2023-10-26 07:00 Eisai, Biogen Build Case for Subcutaneous Leqembi for Alzheimer’s at CTAD - BioSpace
2023-07-07 07:00 US FDA grants standard approval of Eisai/Biogen Alzheimer's drug - Reuters.com
2024-02-13 08:00 Roivant's risky Hemavant bet to wind down after discontinuing ex-Eisai drug - Fierce Biotech
2023-11-07 08:00 Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March - Yahoo Finance
2023-10-26 07:00 Eisai reporting positive data on injectable Alzheimer's drug - Yahoo Finance
2023-09-25 07:00 Merck, Eisai Post Back-to-Back Phase III NSCLC Failures for Keytruda-Lenvima Combo - BioSpace
2023-12-08 08:00 Merck and Eisai's Keytruda-Lenvima combo comes up short yet again, this time in endometrial cancer - FiercePharma

2024-03-11 07:00 Pharma company Eisai backs South African health tech venture RecoMed - ImpactAlpha
2024-03-06 08:00 C₂N Diagnostics, LLC Announces Investment From Eisai Inc. - Business Wire
2023-09-13 07:00 Eisai launches Theoria to build out a 'dementia ecosystem' - FiercePharma
2023-12-22 08:00 Eisai seeks expanded use of Alzheimer's drug for prevention - Nikkei Asia
2023-12-20 08:00 EpiVax Licenses ISPRI Toolkit to Eisai for Preclinical in silico Immunogenicity Screening APAC - English - PR Newswire
2023-06-09 07:00 US FDA panel backs approval for Eisai-Biogen Alzheimer's drug Leqembi - Reuters.com
2024-01-10 08:00 BioArctic AB and Eisai's Leqembi receives approval in China - Pharmaceutical Technology
2024-03-22 07:00 EU regulator delays decision on Eisai-Biogen Alzheimer's drug - Yahoo! Voices
2023-09-14 07:00 Japanese pharma Eisai forms digital dementia support biz - Mobihealth News
2023-10-26 07:00 Eisai, Biogen's injectable Leqembi clears toxic protein in Alzheimer's disease. What about safety? - FiercePharma

2024-02-22 08:00 Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa® - Business Wire
2023-11-16 08:00 Eisai And Eli Lilly Triumph At The 19th Annual Scrip Awards :: Scrip - Scrip
2024-02-28 08:00 EISAI TO PRESENT DATA ON LECANEMAB and OTHER ALZHEIMER'S DISEASE RESEARCH AT THE AD/PD ... - Yahoo Finance
2023-06-09 07:00 FDA panel unanimously endorses Eisai's Alzheimer's drug - STAT
2023-10-27 07:00 BioArctic and Eisai announce new positive data for SC versus IV Leqembi study - Clinical Trials Arena
2023-12-13 08:00 Eisai-Biogen Alzheimer's therapy to cost 2.98 million yen per year - Kyodo News Plus
2023-07-11 07:00 Eisai appoints CEO's son to lead global Alzheimer drug program - The Japan Times
2023-07-11 07:00 Eisai executive who helped lead development of Alzheimer's drug to retire - STAT
2023-07-10 07:00 Eisai Appoints CEO's 34-Year-Old Son to Lead Global Alzheimer Drug Program - Bloomberg
2023-10-26 07:00 Recon: Eisai's injectable version of Alzheimer's drug Leqembi as effective as infusion; J&J weighs bankruptcy as it ... - Regulatory Focus

2023-08-25 07:00 Merck, Eisai Drop Phase III Keytruda-Lenvima Trial for Head and Neck Cancer - BioSpace
2023-09-25 07:00 Japan's Eisai to boost sales staff to focus on new Alzheimer's drug - Nikkei Asia
2023-06-09 07:00 Eisai, Biogen's Leqembi passes muster at FDA adcomm - FiercePharma
2023-07-07 07:00 Biogen, Eisai stocks fall despite receiving FDA approval for Alzheimer's drug - Yahoo Finance
2023-07-22 07:00 Eisai eyes 2024 launch of trials for new Alzheimer's drug - Nikkei Asia
2023-08-25 07:00 Another Keytruda-Lenvima ambition is dashed as Merck, Eisai end head and neck cancer trial - FiercePharma
2023-08-24 07:00 Eisai, Merck & Co.'s Lenvima Patent Clashes Down to Validity - Bloomberg Law
2023-09-26 07:00 Eisai's regulatory progress brings cash flow for BioArctic - BioStock - Connecting Innovation and Capital
2023-07-07 07:00 Leqembi, Eisai Alzheimer’s Drug, Gets Full US Approval and Will See Wider Access - Bloomberg
2023-06-09 07:00 FDA Adcomm Unanimously Backs Full Approval of Eisai, Biogen’s Leqembi - BioSpace

2023-07-18 07:00 New Alzheimer's drug success 'was built on failures': Eisai exec - Yahoo Finance
2023-07-07 07:00 Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug - CNBC
2023-07-06 07:00 Eisai, Biogen snag full, traditional approval for Alzheimer's med Leqembi - FiercePharma
2023-07-06 07:00 FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage - CNBC
2023-07-07 07:00 Biogen, Eisai Alzheimer's drug gets full approval, but faces slow uptake - Yahoo Finance
2023-09-25 07:00 Japan approves Alzheimer's drug developed by Eisai, Biogen - Kyodo News Plus
2023-09-22 07:00 Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer - FiercePharma
2023-07-11 07:00 Eisai's US CEO and Alzheimer's lead Ivan Cheung telegraphs retirement days after Leqembi's full FDA nod - FiercePharma
2023-06-29 07:00 Eisai launches Gates-backed research collab to develop digital tools for dementia diagnosis, treatment - Fierce Biotech
2023-06-07 07:00 Japanese pharma giant Eisai working with law enforcement to resolve ransomware attack - The Record from Recorded Future News

2023-07-13 07:00 Leqembi gets positive feedback from experts: analysts - FiercePharma
2023-06-06 07:00 Eisai hit with ransomware attack, launches investigation into possible data leaks - FiercePharma
2023-09-13 07:00 Eisai launches new digital business company for dementia - PharmaTimes - PharmaTimes
2023-07-06 07:00 Eisai and Biogen Alzheimer's drug lecanemab receives approval from FDA - USA TODAY
2023-07-07 07:00 Companies in Alzheimer's race after US nod for Eisai/Biogen drug - Reuters.com
2023-07-07 07:00 Eisai-Biogen Alzheimer's drug receives full U.S. approval - Nikkei Asia
2023-07-21 07:00 Eisai, Astellas, GSK and more—Fierce Pharma Asia - FiercePharma
2023-09-30 07:34 No Fast Track For Lecanemab In EU Disappoints Eisai - Pink Sheet
2023-06-10 07:00 Eisai-Biogen Alzheimer's drug backed for full U.S. approval - Nikkei Asia

About エーザイ

2024-05-04 from us

Warning: file_get_contents(aCache/search/us/エーザイ): Failed to open stream: No such file or directory in /var/www/hoodb/function.php on line 340

エーザイ, China approves Alzheimer's treatment Leqembi by Eisai and Biogen 2022 エーザイ

China approves Alzheimer's treatment Leqembi by Eisai and Biogen

Choose Your Country or Region

China approves Alzheimer's treatment Leqembi by Eisai and Biogen